CD8-positive primary cutaneous anaplastic large T-Cell Lymphoma (PCALCL): Case report and review of this unusual variant of PCALCL

Jose A. Plaza, Pablo Ortega, James Lynott, Michael Mullane, Steve Kroft, Horatiu Olteanu

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Primary cutaneous anaplastic large T-cell lymphoma (PCALCL) is a well-defined CD30-positive lymphoproliferative disorder with relatively good prognosis and response to treatment. We describe a case of PCALCL expressing CD8. The patient is a 57-year-old man that clinically presented with an ulcerated nodule in his left middle finger. Histopathologic sections showed an ulcerated epidermis with a diffuse lymphocytic infiltrate in the superficial dermis with focal epidermotropism. The large cohesive atypical cells were admixed with a reactive infiltrate composed of neutrophils, eosinophils, and small lymphocytes. Immunohistochemical studies showed the tumor cells to be strongly positive for CD8, CD30, and TIA-1, focally positive for CD3, and negative for CD4, CD20, CD56, Anaplastic Lymphoma Kinase (ALK-1), and HSV. Epstein-Barr virus by in situ hybridization was negative. The diagnosis of a CD8 (+) PCALCL was confirmed. There is limited precedent literature regarding CD8-positive PCALCL and this case falls within the clinical and histopathologic spectrum of CD30+ lymphoproliferative disorders. CD8/CD30 coexpression is rare in PCALCL and may have important clinical and prognostic implications. To the best of our knowledge there are only 4 previously reported cases describing similar findings.

Original languageEnglish (US)
Pages (from-to)489-491
Number of pages3
JournalAmerican Journal of Dermatopathology
Volume32
Issue number5
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Primary Cutaneous Anaplastic Large Cell Lymphoma
T-Cell Lymphoma
Lymphoproliferative Disorders
Human Herpesvirus 1
Dermis
Human Herpesvirus 4
Eosinophils
Epidermis
Fingers
In Situ Hybridization
Neutrophils
Lymphocytes

Keywords

  • primary cutaneous anaplastic large T-cell

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Cite this

CD8-positive primary cutaneous anaplastic large T-Cell Lymphoma (PCALCL) : Case report and review of this unusual variant of PCALCL. / Plaza, Jose A.; Ortega, Pablo; Lynott, James; Mullane, Michael; Kroft, Steve; Olteanu, Horatiu.

In: American Journal of Dermatopathology, Vol. 32, No. 5, 01.07.2010, p. 489-491.

Research output: Contribution to journalArticle

Plaza, Jose A. ; Ortega, Pablo ; Lynott, James ; Mullane, Michael ; Kroft, Steve ; Olteanu, Horatiu. / CD8-positive primary cutaneous anaplastic large T-Cell Lymphoma (PCALCL) : Case report and review of this unusual variant of PCALCL. In: American Journal of Dermatopathology. 2010 ; Vol. 32, No. 5. pp. 489-491.
@article{dbb2067cd4ac4917bb544884c5e3d9cb,
title = "CD8-positive primary cutaneous anaplastic large T-Cell Lymphoma (PCALCL): Case report and review of this unusual variant of PCALCL",
abstract = "Primary cutaneous anaplastic large T-cell lymphoma (PCALCL) is a well-defined CD30-positive lymphoproliferative disorder with relatively good prognosis and response to treatment. We describe a case of PCALCL expressing CD8. The patient is a 57-year-old man that clinically presented with an ulcerated nodule in his left middle finger. Histopathologic sections showed an ulcerated epidermis with a diffuse lymphocytic infiltrate in the superficial dermis with focal epidermotropism. The large cohesive atypical cells were admixed with a reactive infiltrate composed of neutrophils, eosinophils, and small lymphocytes. Immunohistochemical studies showed the tumor cells to be strongly positive for CD8, CD30, and TIA-1, focally positive for CD3, and negative for CD4, CD20, CD56, Anaplastic Lymphoma Kinase (ALK-1), and HSV. Epstein-Barr virus by in situ hybridization was negative. The diagnosis of a CD8 (+) PCALCL was confirmed. There is limited precedent literature regarding CD8-positive PCALCL and this case falls within the clinical and histopathologic spectrum of CD30+ lymphoproliferative disorders. CD8/CD30 coexpression is rare in PCALCL and may have important clinical and prognostic implications. To the best of our knowledge there are only 4 previously reported cases describing similar findings.",
keywords = "primary cutaneous anaplastic large T-cell",
author = "Plaza, {Jose A.} and Pablo Ortega and James Lynott and Michael Mullane and Steve Kroft and Horatiu Olteanu",
year = "2010",
month = "7",
day = "1",
doi = "10.1097/DAD.0b013e3181c57ec2",
language = "English (US)",
volume = "32",
pages = "489--491",
journal = "American Journal of Dermatopathology",
issn = "0193-1091",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - CD8-positive primary cutaneous anaplastic large T-Cell Lymphoma (PCALCL)

T2 - Case report and review of this unusual variant of PCALCL

AU - Plaza, Jose A.

AU - Ortega, Pablo

AU - Lynott, James

AU - Mullane, Michael

AU - Kroft, Steve

AU - Olteanu, Horatiu

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Primary cutaneous anaplastic large T-cell lymphoma (PCALCL) is a well-defined CD30-positive lymphoproliferative disorder with relatively good prognosis and response to treatment. We describe a case of PCALCL expressing CD8. The patient is a 57-year-old man that clinically presented with an ulcerated nodule in his left middle finger. Histopathologic sections showed an ulcerated epidermis with a diffuse lymphocytic infiltrate in the superficial dermis with focal epidermotropism. The large cohesive atypical cells were admixed with a reactive infiltrate composed of neutrophils, eosinophils, and small lymphocytes. Immunohistochemical studies showed the tumor cells to be strongly positive for CD8, CD30, and TIA-1, focally positive for CD3, and negative for CD4, CD20, CD56, Anaplastic Lymphoma Kinase (ALK-1), and HSV. Epstein-Barr virus by in situ hybridization was negative. The diagnosis of a CD8 (+) PCALCL was confirmed. There is limited precedent literature regarding CD8-positive PCALCL and this case falls within the clinical and histopathologic spectrum of CD30+ lymphoproliferative disorders. CD8/CD30 coexpression is rare in PCALCL and may have important clinical and prognostic implications. To the best of our knowledge there are only 4 previously reported cases describing similar findings.

AB - Primary cutaneous anaplastic large T-cell lymphoma (PCALCL) is a well-defined CD30-positive lymphoproliferative disorder with relatively good prognosis and response to treatment. We describe a case of PCALCL expressing CD8. The patient is a 57-year-old man that clinically presented with an ulcerated nodule in his left middle finger. Histopathologic sections showed an ulcerated epidermis with a diffuse lymphocytic infiltrate in the superficial dermis with focal epidermotropism. The large cohesive atypical cells were admixed with a reactive infiltrate composed of neutrophils, eosinophils, and small lymphocytes. Immunohistochemical studies showed the tumor cells to be strongly positive for CD8, CD30, and TIA-1, focally positive for CD3, and negative for CD4, CD20, CD56, Anaplastic Lymphoma Kinase (ALK-1), and HSV. Epstein-Barr virus by in situ hybridization was negative. The diagnosis of a CD8 (+) PCALCL was confirmed. There is limited precedent literature regarding CD8-positive PCALCL and this case falls within the clinical and histopathologic spectrum of CD30+ lymphoproliferative disorders. CD8/CD30 coexpression is rare in PCALCL and may have important clinical and prognostic implications. To the best of our knowledge there are only 4 previously reported cases describing similar findings.

KW - primary cutaneous anaplastic large T-cell

UR - http://www.scopus.com/inward/record.url?scp=77954143765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954143765&partnerID=8YFLogxK

U2 - 10.1097/DAD.0b013e3181c57ec2

DO - 10.1097/DAD.0b013e3181c57ec2

M3 - Article

C2 - 20442639

AN - SCOPUS:77954143765

VL - 32

SP - 489

EP - 491

JO - American Journal of Dermatopathology

JF - American Journal of Dermatopathology

SN - 0193-1091

IS - 5

ER -